Anatomical, Functional and Molecular Biomarker Applications of Magnetic Resonance Neuroimaging

Overview

Journal Future Neurol

Specialty Neurology

Date 2015 Mar 17

PMID 25774094

Citations 1

Authors

Christina H Liu

Affiliations

Soon will be listed here.

Abstract

MRI and magnetic resonance spectroscopy (MRS) along with computed tomography and PET are the most common imaging modalities used in the clinics to detect structural abnormalities and pathological conditions in the brain. MRI generates superb image resolution/contrast without radiation exposure that is associated with computed tomography and PET; MRS and spectroscopic imaging technologies allow us to measure changes in brain biochemistry. Increasingly, neurobiologists and MRI scientists are collaborating to solve neuroscience problems across sub-cellular through anatomical levels. To achieve successful cross-disciplinary collaborations, neurobiologists must have sufficient knowledge of magnetic resonance principles and applications in order to effectively communicate with their MRI colleagues. This review provides an overview of magnetic resonance techniques and how they can be used to gain insight into the active brain at the anatomical, functional and molecular levels with the goal of encouraging neurobiologists to include MRI/MRS as a research tool in their endeavors.

Citing Articles

Obstructive sleep apnea and attention deficits: A systematic review of magnetic resonance imaging biomarkers and neuropsychological assessments.

Ghaderi S, Mohammadi S, Mohammadi M Brain Behav. 2023; 13(11):e3262.

PMID: 37743582 PMC: 10636416. DOI: 10.1002/brb3.3262.

References

Mandeville J, Liu C, Vanduffel W, Marota J, Jenkins B . Data collection and analysis strategies for phMRI. Neuropharmacology. 2014; 84:65-78. PMC: 4058391. DOI: 10.1016/j.neuropharm.2014.02.018. View

Jacobs H, Visser P, van Boxtel M, Frisoni G, Tsolaki M, Papapostolou P . Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiol Aging. 2010; 33(1):201.e1-8. DOI: 10.1016/j.neurobiolaging.2010.07.015. View

Mandeville J, Jenkins B, Chen Y, Choi J, Kim Y, Belen D . Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4 T. Magn Reson Med. 2004; 52(6):1272-81. DOI: 10.1002/mrm.20278. View

Haukvik U, Hartberg C, Agartz I . Schizophrenia--what does structural MRI show?. Tidsskr Nor Laegeforen. 2013; 133(8):850-3. DOI: 10.4045/tidsskr.12.1084. View

Liu C, You Z, Liu C, Kim Y, Whalen M, Rosen B . Diffusion-weighted magnetic resonance imaging reversal by gene knockdown of matrix metalloproteinase-9 activities in live animal brains. J Neurosci. 2009; 29(11):3508-17. PMC: 2726707. DOI: 10.1523/JNEUROSCI.5332-08.2009. View

Koffie R, Farrar C, Saidi L, William C, Hyman B, Spires-Jones T . Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging. Proc Natl Acad Sci U S A. 2011; 108(46):18837-42. PMC: 3219113. DOI: 10.1073/pnas.1111405108. View

Liu J, Ghassemi M, Michael A, Boutte D, Wells W, Perrone-Bizzozero N . An ICA with reference approach in identification of genetic variation and associated brain networks. Front Hum Neurosci. 2012; 6:21. PMC: 3284145. DOI: 10.3389/fnhum.2012.00021. View

Tietze A, Blicher J, Mikkelsen I, Ostergaard L, Strother M, Smith S . Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI. NMR Biomed. 2013; 27(2):163-74. PMC: 4019439. DOI: 10.1002/nbm.3048. View

Liu C, Ren J, Yang J, Liu C, Mandeville J, Rosen B . DNA-based MRI probes for specific detection of chronic exposure to amphetamine in living brains. J Neurosci. 2009; 29(34):10663-70. PMC: 2746375. DOI: 10.1523/JNEUROSCI.2167-09.2009. View

10.

Zeineh M, Holdsworth S, Skare S, Atlas S, Bammer R . Challenges of High-resolution Diffusion Imaging of the Human Medial Temporal Lobe in Alzheimer Disease. Top Magn Reson Imaging. 2011; 21(6):355-65. PMC: 3238799. DOI: 10.1097/RMR.0b013e31823f6413. View

11.

Kwong K, Belliveau J, Chesler D, Goldberg I, Weisskoff R, Poncelet B . Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A. 1992; 89(12):5675-9. PMC: 49355. DOI: 10.1073/pnas.89.12.5675. View

12.

Menke R, Jbabdi S, Miller K, Matthews P, Zarei M . Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease. Neuroimage. 2010; 52(4):1175-80. DOI: 10.1016/j.neuroimage.2010.05.086. View

13.

Ahrens E, Zhong J . In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection. NMR Biomed. 2013; 26(7):860-71. PMC: 3893103. DOI: 10.1002/nbm.2948. View

14.

Chaumeil M, Ozawa T, Park I, Scott K, James C, Nelson S . Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma. Neuroimage. 2011; 59(1):193-201. PMC: 3196046. DOI: 10.1016/j.neuroimage.2011.07.034. View

15.

Rajca A, Wang Y, Boska M, Paletta J, Olankitwanit A, Swanson M . Organic radical contrast agents for magnetic resonance imaging. J Am Chem Soc. 2012; 134(38):15724-7. PMC: 3486519. DOI: 10.1021/ja3079829. View

16.

Gordon Y, Partovi S, Muller-Eschner M, Amarteifio E, Bauerle T, Weber M . Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusion. Cardiovasc Diagn Ther. 2014; 4(2):147-64. PMC: 3996240. DOI: 10.3978/j.issn.2223-3652.2014.03.01. View

17.

Abd-El-Barr M, Saleh E, Huang R, Golby A . Effect of disease and recovery on functional anatomy in brain tumor patients: insights from functional MRI and diffusion tensor imaging. Imaging Med. 2014; 5(4):333-346. PMC: 3959954. DOI: 10.2217/iim.13.40. View

18.

Grefkes C, Fink G . Connectivity-based approaches in stroke and recovery of function. Lancet Neurol. 2014; 13(2):206-16. DOI: 10.1016/S1474-4422(13)70264-3. View

19.

Gauthier L, Taub E, Mark V, Barghi A, Uswatte G . Atrophy of spared gray matter tissue predicts poorer motor recovery and rehabilitation response in chronic stroke. Stroke. 2011; 43(2):453-7. PMC: 3265680. DOI: 10.1161/STROKEAHA.111.633255. View

20.

Ronald J, Chen J, Chen Y, Hamilton A, Rodriguez E, Reynolds F . Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques. Circulation. 2009; 120(7):592-9. PMC: 2736635. DOI: 10.1161/CIRCULATIONAHA.108.813998. View